Amifostine Pretreatment Attenuates Myocardial Ischemia/Reperfusion Injury by Inhibiting Apoptosis and Oxidative Stress

作者：Wu, Shao-ze; Tao, Lu-yuan; Wang, Jiao-ni; Xu, Zhi-qiang; Wang, Jie; Xue, Yang-jing; Huang, Kai-yu; Lin, Jia-feng; Li, Lei; Ji, Kang-ting^*

来源：Oxidative Medicine and Cellular Longevity, 2017, 2017: 4130824.

DOI：10.1155/2017/4130824

• ISCHEMIA-REPERFUSION
• MITOCHONDRIAL DYSFUNCTION
• MECHANISMS
• RADIATION
• PROTECTS
• CELLS

The present study was aimed at investigating the effect of amifostine on myocardial ischemia/reperfusion (I/R) injury of mice and H9c2 cells cultured with TBHP (tert-butyl hydroperoxide). The results showed that pretreatment with amifostine significantly attenuated cell apoptosis and death, accompanied by decreased reactive oxygen species (ROS) production and lower mitochondrial potential (Delta psi m). In vivo, amifostine pretreatment alleviated I/R injury and decreasedmyocardial apoptosis and infarct area, which was paralleled by increased superoxide dismutase (SOD) and reduced malondialdehyde (MDA) in myocardial tissues, increased Bcl2 expression, decreased Bax expression, lower cleaved caspase-3 level, fewer TUNEL positive cells, and fewer DHE-positive cells in heart. Our results indicate that amifostine pretreatment has a protective effect againstmyocardial I/R injury via scavenging ROS.

• 出版日期2017
• 单位温州医科大学